MAPT and Alzheimer disease: Notably, plasma TIA-1 mirrored the discriminatory patterns of CSF t-Tau and p-Tau, distinguishing non-AD neurodegenerative diseases from specifically rpAD subtype, indicating that plasma TIA-1 captures the same underlying pathophysiological processes as the “gold standard” CSF markers.